Medicines Shortages Update
Last Updated 25 May 2026
NOTE: For any reimbursement queries relating to EMPs please contact PCRS – ExemptMed@hse.ie.
| Tradename | Pack Size | GMS No | Expected Resupply Date | Manufacturer | Date Notified | Date Last Updated | Date Resolved | Reason | Generic Name | Note | Reimbursement of EMP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ABILIFY MAINTENA 400MG PDR&SOLV PR INJ | 1VIAL | 67257 | Back In Stock | PCO | 16-Mar-26 | 22-May-26 | 22-May-26 | Unexpected increased demand | ARIPIPRAZOLE | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ABILIFY MAINTENA 960MG PR SUSP/INJ PFS | 1SYR | 67196 | 1st June 2026 | LUNDBECK | 12-May-26 | 22-May-26 | Manufacturing delay | ARIPIPRAZOLE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ACETYLCYSTEINE ESSENTIAL 600MG EFF TABS | 30TABS | 64004 | 31st August 2026 | ASCOT LABS | 18-Jun-24 | 20-May-26 | No reason provided | ACETYLCYSTEINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| ACIDEX LIQUID ORAL SUSPENSION | 200ML | Unable to provide date | PINEWOOD | 23-Jan-25 | 14-Jan-26 | Reformulation / regulatory issue | SOD ALG/SOD H CARB/CACARB | As per Pinewood | |||
| ACIDEX LIQUID ORAL SUSPENSION | 500ML | Unable to provide date | PINEWOOD | 23-Jan-25 | 14-Jan-26 | Reformulation / regulatory issue | SOD ALG/SOD H CARB/CACARB | As per Pinewood | |||
| ACTIQ 200MCG COMPRESSED LOZENGE C APPLIC | 30LOZ | 32104 | Jun-26 | PHOENIX | 18-Dec-25 | 21-May-26 | Manufacturing delay | FENTANYL | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ACTIQ 600MCG COMPRESSED LOZENGE C APPLIC | 30LOZ | 45637 | Jun-26 | PHOENIX | 05-Feb-26 | 21-May-26 | No reason provided | FENTANYL | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ADDIPHOS CONC FOR SOLN/INF 20ML POA | 10VIAL | Pending | FRES KABI | 12-Jan-26 | 13-Mar-26 | API shortage/ unavailability | POTASSIUM/PHOSPHAT/SODIUM | As per HPRA | |||
| ADENOCOR 3MG/ML SOLN FOR INJ 2ML | 6VIAL | TBC | SANOFI AVE | 12-May-26 | Managing remaining stocks until next resupply | ADENOSINE | As per Sanofi | ||||
| ALENDRONATE/COLECA TEVA 70MG/2800IU TABS | 4TABS | 13480 | Aug-26 | TEVA | 27-Apr-26 | 20-May-26 | Manufacturing delay | ALENDRONIC AC/COLECALCIFE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ALOPUR 100MG TABS ALLOPURINOL | 100TABS | 10652 | End May 2026 | ROWA | 01-Apr-26 | 20-May-26 | QA issue | ALLOPURINOL | As per Rowa. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AMLODIPINE TEVA 5MG TABS | 28TABS | 15078 | OOS expected 31st May - 3rd August 2026 | TEVA | 15-May-26 | Manufacturing delay | AMLODIPINE | As per HPRA | |||
| AMLODIPINE/VALSARTAN MYLAN 10/160MG TAB | 28TABS | 24533 | 1st September 2026 | VIATRIS | 26-Nov-25 | 20-May-26 | Manufacturing delay | AMLODIPINE/VALSARTAN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AMLODIPINE/VALSARTAN MYLAN 5MG/160MG TAB | 28TABS | 24532 | 20th July 2026 | VIATRIS | 28-Apr-26 | 20-May-26 | Manufacturing delay | AMLODIPINE/VALSARTAN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AMOROLFINE 5%W/V MEDICATED NAIL LACQUER | 5ML | 31464 | Awaiting further update | ROWA | 06-Feb-26 | 20-May-26 | Manufacturing delay | AMOROLFINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ANAPEN 500MCG/0.3ML SOLN/INJ ADULT PFS | 2SYR | 39108 | Jul-26 | LINCOLNMED | 04-Sep-24 | 20-May-26 | Manufacturing issues | EPINEPHRINE | As per Bioprojet | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ANASTROZOLE 1MG FC TABS | 28TABS | 12953 | Back In Stock | ACCORD HC | 11-Nov-25 | 22-May-26 | 22-May-26 | Delivery delayed | ANASTROZOLE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ANTI-HIST ALLERGY 1MG/ML ORAL SOLUTION | 200ML | Early July 2026 | CLONMEL | 10-Apr-26 | 22-May-26 | Manufacturing delay | CETIRIZINE | As per Clonmel | |||
| APREPITANT ACCORD 125MG HARD CAPS | 5CAPS | 28903 | Feb-27 | ACCORD HC | 04-Feb-26 | 20-May-26 | Manufacturing delay | APREPITANT | As per Accord | Considered on a patient specific basis - Individual Reimbursement Request Application Form (IRF) required | |
| APREPITANT ACCORD 125MG/80MG CAPS 3 DAY | 1PACK | 28906 | Feb-27 | ACCORD HC | 18-Feb-25 | 20-May-26 | Manufacturing delay | APREPITANT | As per Accord | Considered on a patient specific basis - Individual Reimbursement Request Application Form (IRF) required | |
| APREPITANT ACCORD 80MG HARD CAPS 2 DAY | 1PACK | 28904 | Feb-27 | ACCORD HC | 12-May-25 | 20-May-26 | Manufacturing delay | APREPITANT | As per Accord | Considered on a patient specific basis - Individual Reimbursement Request Application Form (IRF) required | |
| ARIPIL 5MG FC TABS DONEPEZIL | 28TABS | 12275 | 1st January 2027 | VIATRIS | 18-Feb-26 | 25-May-26 | Unexpected increased demand | DONEPEZIL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ARTHROTEC 50MG MOD REL TABS | 60TABS | 13102 | OOS expected 1st-22nd June 2026 | PFIZER | 18-May-26 | Manufacturing delay | DICLOFENAC SOD/MISOPROSTO | As per HPRA | |||
| ATGAM 50MG/ML CONC/SOLN/INF 5ML POA | 5AMP | 15th July 2026 | PFIZER | 15-Jan-26 | 25-May-26 | Unexpected increased demand | ANTITHYMO IMMUNOGLOB EQUI | As per HPRA | |||
| ATOMOXETINE ACCORD 100MG HARD CAPS | 28CAPS | 36009 | Nov-26 | ACCORD HC | 06-Jun-24 | 22-May-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 10MG HARD CAPS | 28CAPS | 36001 | Nov-26 | ACCORD HC | 06-Jun-24 | 22-May-26 | Manufacturing delay | ATOMOXETINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 10MG HARD CAPS | 7CAPS | 36000 | Nov-26 | ACCORD HC | 06-Jun-24 | 22-May-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 25MG HARD CAPS | 28CAPS | 36005 | Nov-26 | ACCORD HC | 06-Jun-24 | 22-May-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 25MG HARD CAPS | 7CAPS | 36004 | Nov-26 | ACCORD HC | 06-Jun-24 | 22-May-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATORVASTATIN 80MG FC TABS | 28TABS | 25398 | Early June 2026 | ACCORD HC | 30-Apr-26 | 22-May-26 | Shipping delay / distribution issue | ATORVASTATIN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATORVASTATIN VIATRIS 20MG FC TABS | 28TABS | 41966 | No back in stock date available at the moment | VIATRIS | 07-Apr-25 | 20-May-26 | Manufacturing delay | ATORVASTATIN | As per Viatris. HPRA shows return date as Pending | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATORVASTATIN VIATRIS 40MG FC TABS | 28TABS | 41967 | No back in stock date available at the moment | VIATRIS | 21-Mar-25 | 20-May-26 | Manufacturing delay | ATORVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATORVASTATIN VIATRIS 80MG FC TABS | 28TABS | 41968 | No back in stock date available at the moment | VIATRIS | 14-Apr-25 | 20-May-26 | Manufacturing delay | ATORVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATOZET 10MG/10MG FC TABS IMED | 30TABS | No return date | IMED | 20-Jan-26 | 20-Apr-26 | Commercial issues | EZETIMIBE/ATORVASTATIN | As per IMED | |||
| ATOZET 10MG/40MG FC TABS | 30TABS | 36862 | 4th June 2026 | ORGANON | 16-Apr-26 | 21-May-26 | Quality issue | EZETIMIBE/ATORVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATOZET 10MG/40MG TABS IMED | 30TABS | No return date | IMED | 20-Jan-26 | 20-Apr-26 | Commercial issues | EZETIMIBE/ATORVASTATIN | As per IMED | |||
| ATOZET 10MG/80MG TABS IMED | 30TABS | No return date | IMED | 20-Jan-26 | 20-Apr-26 | Commercial issues | EZETIMIBE/ATORVASTATIN | As per IMED | |||
| ATRACURIUM BESILATE 10MG/ML 2.5ML | 5VIAL | Not relaunched to date | CARAGEN | 17-Jan-25 | 21-Apr-26 | Awaiting information | ATRACURIUM | As per Caragen | |||
| AZACITIDINE ACCORD 25MG/ML PDR/SUSP/INJ | 1VIAL | Pending | ACCORD HC | 06-Feb-26 | Manufacturing delay | AZACITIDINE | As per HPRA | ||||
| AZACITIDINE ACCORD 25MG/ML PDR/SUSP/INJ | 1VIAL | No return date (150ML) | ACCORD HC | 26-Mar-26 | 21-Apr-26 | Reason provided | AZACITIDINE | As per Accord | |||
| AZITHROMYCIN CLONMEL 250MG FC TABS | 6TABS | 47968 | TBC | CLONMEL | 29-Jan-26 | 22-May-26 | Manufacturing delay | AZITHROMYCIN | As per Clonmel. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BECLAZONE 200MCG EASI BREATHE INH 200 DS | 1INHLR | 14111 | Back In Stock | TEVA | 16-Oct-25 | 21-May-26 | 21-May-26 | No reason providedq | BECLOMETASONE DIPROPIONAT | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| BENDAMUSTINE 100MG PDR/CONC/SOLN FOR INF | 5VIAL | No return date | ACCORD HC | 23-Jan-25 | 27-Mar-26 | No reason pprovided | BENDAMUSTINE | As per Accord | |||
| BENDAMUSTINE RTU 25MG CONC/SOLN FOR INF | 1VIAL | Back In Stock | ACCORD HC | 04-Apr-25 | 22-May-26 | 22-May-26 | Unexpected increased demand | BENDAMUSTINE | As per Accord | ||
| BENDROFLUMETHIAZIDE 2.5MG TABS | 28TABS | 36979 | Q4 2026 | AZURE | 28-Jan-25 | 20-May-26 | Undergoing testing | BENDROFLUMETHIAZIDE | As per Azure (HPRA shows 31.10.26 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BENDROFLUMETHIAZIDE 5MG TABS | 28TABS | 36980 | Q4 2026 | AZURE | 16-Jul-25 | 20-May-26 | Delay in securing EU QP release services | BENDROFLUMETHIAZIDE | As per Azure (HPRA shows 31.10.26 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BENZYL BENZOATE 25% APPLICATION CUT EMUL | 150ML | Pending | OVELLE | 31-Jul-25 | 05-Feb-26 | API shortage / unavailability | BENZYL BENZOATE | As per HPRA 05.02.26 | |||
| BETNESOL 0.1% EYE EAR & NOSE DROPS | 10ML | 15113 | 31st May 2026 | RPH | 29-Apr-26 | 20-May-26 | Manufacturing delay | BETAMETHASONE SODIUM PHOS | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BETNESOL N EYE EAR & NASAL DROPS | 10ML | 15121 | Return date pending | RPH | 01-May-26 | 22-May-26 | Manufacturing delay | BETAMETHASON NA PHOS/NEOM | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BETNOVATE 0.1% CREAM | 30G | 14893 | 25th May 2026 | GSK MED | 24-Feb-26 | 20-May-26 | Quality issue | BETAMETHASONE VALERATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BRILLPHALAC 3.335G/5 ML ORAL SOLUTION | 300ML | Q4 2026 | WINDZOR PH | 17-Feb-25 | 06-Mar-26 | Change of manufacturing site | LACTULOSE | As per Windzor. HPRA shows 30.06.2026 return date | |||
| BRILLPHALAC 3.335G/5 ML ORAL SOLUTION | 500ML | 67152 | Q4 2026 | WINDZOR PH | 17-Feb-25 | 20-May-26 | Change of manufacturing site | LACTULOSE | As per Windzor. HPRA shows 30.06.2026 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BRINAVESS 20MG/ML CONC FOR SOLN/INF 25ML | 1VIAL | No confirmed timeline (UK packs may be avail) | ADVANZ | 17-Nov-25 | 30-Mar-26 | Regulatory issue | VERNAKALANT | As per Advanz (ULM UK packs may be avail). HPRA shows 31.12.26 return date | |||
| BROLENE 0.1% EYE DROPS SOLN | 10ML | Early August 2026 | CLONMEL | 21-May-26 | 22-May-26 | Manufacturing delay | PROPAMIDINE | As per Clonmel | |||
| BROLENE 0.15% EYE OINTMENT | 5G | MidJune 2026 | CLONMEL | 27-Nov-24 | 22-May-26 | API unavailability | DIBROMPROPAMIDINE | As per Clonmel | |||
| BUDESONIDE TEVA PHARM 0.5MG/2ML NEB SUSP | 20NEB | 76605 | 2026 | TEVA | 04-Dec-24 | 20-May-26 | Manufacturing delay | BUDESONIDE | As per Teva (HPRA shows 26.06.26 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BUDESONIDE TEVA PHARMA 1MG/2ML NEB SUSP | 20NEB | 13341 | 2026 | TEVA | 02-Jan-25 | 20-May-26 | Manufacturing delay | BUDESONIDE | As per Teva (HPRA shows 26.06.26 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BUPIVACAINE HCL 0.25% SOLN/INJ 10ML | 10AMP | Back In Stock | ADVANZ | 05-May-26 | 25-May-26 | 22-May-26 | Delivery delay | BUPIVACAINE | As per Advanz | ||
| BURINEX 1MG TABS | 30TABS | 31596 | 30th June 2026 | KARO | 31-Oct-25 | 20-May-26 | Manufacturer cannot supply | BUMETANIDE | As per HPRA. UD expect update on resupply in June. (On allocation when in stock) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CELECOXIB 100MG HARD CAPS | 60CAPS | 13406 | 15th June 2026 | ACCORD HC | 04-Feb-26 | 20-May-26 | Manufacturing delay | CELECOXIB | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CELECOXIB 200MG HARD CAPS | 30CAPS | 13407 | 15th June 2026 | ACCORD HC | 04-Feb-26 | 20-May-26 | Manufacturing delay | CELECOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CELECOXIB KRKA 200MG HARD CAPS | 30CAPS | 13409 | 15th June 2026 | KRKA PHARM | 07-May-26 | 22-May-26 | No reason provided | CELECOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CHLOROMYCETIN 0.5% REDI-DROPS EYE DROPS | 10ML | 67318 | No confirmed timeline | ADVANZ | 05-Aug-25 | 20-May-26 | Manufacturing issue | CHLORAMPHENICOL | As per Advanz | EMP reimbursed for duration of HPRA registered shortage | |
| CINACALCET ACCORDPHARMA 30MG FC TABS | 28TABS | 89046 | TBC | ACCORD HC | 21-Mar-25 | 20-May-26 | Manufacturing delay | CINACALCET | As per Accord (HPRA shows July 2027 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET ACCORDPHARMA 60MG FC TABS | 28TABS | 89047 | TBC | ACCORD HC | 21-Mar-25 | 20-May-26 | Manufacturing delay | CINACALCET | As per Accord (HPRA shows July 2027 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET ACCORDPHARMA 90MG FC TABS | 28TABS | 89048 | TBC | ACCORD HC | 14-Feb-25 | 20-May-26 | No reason provided | CINACALCET | As per Accord (HPRA shows July 2027 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET TEVA 30MG FC TABS | 28TABS | 89080 | 2026 | TEVA | 08-Jun-23 | 20-May-26 | No reason provided | CINACALCET | As per Teva. HPRA shows June 2026 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET TEVA 60MG FC TABS | 28TABS | 89081 | 2026 | TEVA | 27-Jul-23 | 20-May-26 | No reason provided | CINACALCET | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET TEVA 90MG FC TABS | 28TABS | 89082 | 2026 | TEVA | 03-Aug-23 | 20-May-26 | No reason provided | CINACALCET | As per Teva. HPRA shows June 2026 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CIPROFLOXACIN TEVA 500MG FC TABS | 10TABS | 18952 | TBC | TEVA | 21-Nov-24 | 20-May-26 | Capacity issues | CIPROFLOXACIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CIPROFLOXACIN TEVA 500MG FC TABS | 20TABS | 18974 | TBC | TEVA | 27-Feb-25 | 20-May-26 | No reason provided | CIPROFLOXACIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CLAFORAN 500MG PDR FOR SOLN FOR INJ | 1VIAL | End June 2026 | ADVANZ | 31-Dec-25 | 23-Mar-26 | Delivery delay | CEFOTAXIME | As per Advanz | |||
| CLARITHROMYCIN 500MG PDR CONC SOLN/INF | 1VIAL | No confirmed timeline | ADVANZ | 09-Feb-26 | Prolonged manufacturing issue. Short-dated stock (expiry 30/04/2026) remains available for order | CLARITHROMYCIN | As per Advanz | ||||
| CLONFOLIC 0.4MG TABS | 28TABS | TBC | CLONMEL | 08-Jul-24 | 22-May-26 | Quality issue | FOLIC ACID | As per Clonmel | |||
| CLONFOLIC 0.4MG TABS | 98TABS | 18176 | TBC | CLONMEL | 05-Jul-24 | 22-May-26 | Quality issue | FOLIC ACID | As per Clonmel. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CLONOCID 500MG FC TABS CLARITHROMYCIN | 14TABS | 18143 | Early July 2026 | CLONMEL | 26-Jan-26 | 22-May-26 | No reason provided | CLARITHROMYCIN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CLOZARIL 100MG TABS | 84TABS | Back In Stock | VIATRIS | 18-Mar-26 | 25-May-26 | 22-May-26 | Quality issue | CLOZAPINE | As per Viatris | ||
| CO-AMOXICLAV TEVA 500MG/100MG PDRINJINF | 10VIAL | TBC | TEVA | 08-Mar-24 | 22-Jan-26 | Unexpected increase in demand | CO-AMOXICLAV | As per Teva | |||
| COCOIS OINTMENT | 100G | 18769 | Pending | RPH | 18-Jun-24 | 20-May-26 | Regulatory issue | COAL TAR/SULFUR/SALICYLIC | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| COCOIS OINTMENT | 40G | 18757 | Pending | RPH | 18-Jun-24 | 20-May-26 | Regulatory issue | COAL TAR/SULFUR/SALICYLIC | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CORTIMENT 9MG PRO REL TABS | 30TABS | 36833 | 16th May 2026 | FERRING | 20-Mar-26 | 20-May-26 | Unexpected increased demand | BUDESONIDE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CRESTOR 10MG FC TABS | 28TABS | 19164 | 25th June 2026 | GRUNENTHAL | 15-May-26 | 20-May-26 | Manufacturing delay | ROSUVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CYTOTEC 200MCG TABS | 60TABS | 19951 | 1st June 2026 | PFIZER | 11-May-26 | 22-May-26 | Unexpected increased demand | MISOPROSTOL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DAKTARIN 20MG/G ORAL GEL | 40G | 77623 | 2027 | JOHN&JOHN | 19-Mar-26 | 20-May-26 | Quality issue | MICONAZOLE | As per J&J | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DEPREGER 100MG FC TABS SERTRALINE | 28TABS | 20784 | No back in stock date available at the moment | VIATRIS | 22-Aug-24 | 20-May-26 | No reason provided | SERTRALINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DEPREGER 50MG FC TABS SERTRALINE | 28TABS | 20713 | No back in stock date available at the moment | VIATRIS | 06-Nov-24 | 20-May-26 | No reason provided | SERTRALINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DESENEX POWDER | 55G | TBC | CLONMEL | 20-Jun-25 | 22-May-26 | Manufacturing delay | ZINC UNDECYL/UNDECYL ACID | As per Clonmel | |||
| DESLOR 0.5MG/ML ORAL SOLN DESLORATADINE | 100ML | 35803 | Awaiting update | ROWA | 24-Apr-26 | 20-May-26 | Stock in release process | DESLORATADINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DETRUSITOL SR 2MG PRO REL HARD CAPS | 28CAPS | 53651 | 1st June 2026 | VIATRIS | 01-May-26 | 25-May-26 | Unexpected increase in demand | TOLTERODINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DETRUSITOL SR 4MG PRO REL HARD CAPS | 28CAPS | 53662 | 1st June 2026 | VIATRIS | 01-May-26 | 20-May-26 | Unexpected increased demand | TOLTERODINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DEXAMETHASONE PHOS NORIDEM 4MG/ML 1ML | 10AMP | Not relaunched to date | CARAGEN | 01-Apr-26 | 21-Apr-26 | Manufacturing delay | DEXAMETHASONE PHOSPHATE | As per Caragen | |||
| DONEPEZIL 10MG FC TABS | 28TABS | 69088 | Back In Stock | ACCORD HC | 06-Feb-26 | 22-May-26 | 22-May-26 | Unexpected increased demand | DONEPEZIL | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| DOSTINEX 500MCG TABS | 8TABS | 22406 | OOS expected 1st - 30th June 2026 | PFIZER | 19-May-26 | API Shortage / unavailability | CABERGOLINE | As per HPRA | |||
| DOXORUBICIN 2MG/ML CONC SOLNINF 50ML POA | 1VIAL | Discontinued | ACCORD HC | 18-Nov-24 | 22-May-26 | 22-May-26 | Long term shortage | DOXORUBICIN | As per Accord HPRA shows Not Marketed | ||
| DOXORUBICIN 2MG/ML CONCSOLNINF 100ML | 1VIAL | Discontinued | ACCORD HC | 18-Nov-24 | 22-May-26 | 22-May-26 | Long term shortage | DOXORUBICIN | As per Accord HPRA shows Not Marketed | ||
| DOXORUBICIN TEVA 2MG/ML CONC/INF 5ML | 1VIAL | TBC | TEVA | 17-Apr-25 | 26-Mar-26 | No reason provided | DOXORUBICIN | As per Teva | |||
| DOZEPT 5MG FC TABS DONEPEZIL | 28TABS | 69036 | 1st June 2026 | ROWA | 24-Apr-26 | 20-May-26 | Unexpected increase in sales | DONEPEZIL | As per Rowa. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE 30MG GAST RES CAPS | 28CAPS | 37031 | No return date | ACCORD HC | 16-Sep-24 | 20-May-26 | Quality issue | DULOXETINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE 60MG GAST RES CAPS | 28CAPS | 37032 | No return date | ACCORD HC | 20-Mar-24 | 20-May-26 | Quality issue | DULOXETINE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE CLONMEL 30MG GAST RES CAPS | 28CAPS | 37023 | TBC | CLONMEL | 26-Jan-26 | 22-May-26 | No reason provided | DULOXETINE | As per Clonmel. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE CLONMEL 60MG GAST RES CAPS | 28CAPS | 37034 | TBC | CLONMEL | 16-Dec-25 | 22-May-26 | No reason provided | DULOXETINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE VIATRIS 30MG GAST RES CAPS | 28CAPS | 36818 | 1st April 2027 | VIATRIS | 31-Mar-26 | 20-May-26 | Quality issue | DULOXETINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE VIATRIS 60MG GAST RES CAPS | 28CAPS | 36819 | 1st April 2027 | VIATRIS | 27-Apr-26 | 20-May-26 | Quality issue | DULOXETINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUTASTERIDE 0.5MG SOFT CAPS | 30CAPS | 54320 | TBC | TEVA | 30-Mar-26 | 20-May-26 | Unexpected increased demand | DUTASTERIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUTASTERIDE ROWA 0.5MG SOFT CAPS | 30CAPS | 54327 | Return date TBC | ROWA | 14-May-26 | 25-May-26 | Increase in sales | DUTASTERIDE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUTASTERIDE/TAMSULO ROWA 0.5/0.4MG CAPS | 30CAPS | 54303 | End May 2026 | ROWA | 04-Mar-26 | 20-May-26 | Unprecedented demand | DUTASTERIDE/TAMSULOSIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EFUDIX 5% CREAM | 20G | 64351 | Jun-26 | VIATRIS | 15-Aug-25 | 20-May-26 | Temporary supply constraints due to capacity expansion at the manufacturing site. Limited allocations may be available. | FLUOROURACIL | As per HPRA / Viatris DHCP letter. Fixed quantities of Efudix will be supplied each month. Stock should be available to order at the start of each month. It is advisable, to contact your wholesaler and ask to be put on a reserve list for this stock. Please contact Uniphar or United Drug to place a back order. | EMP reimbursed for duration of HPRA registered shortage | |
| EFUDIX 5% CREAM | 40G | 64360 | Jun-26 | VIATRIS | 15-Aug-25 | 20-May-26 | Temporary supply constraints due to capacity expansion at the manufacturing site. Limited allocations may be available. | FLUOROURACIL | As per HPRA / Viatris DHCP letter. Fixed quantities of Efudix will be supplied each month. Stock should be available to order at the start of each month. It is advisable, to contact your wholesaler and ask to be put on a reserve list for this stock. Please contact Uniphar or United Drug to place a back order. | EMP reimbursed for duration of HPRA registered shortage | |
| ELANTAN 20MG TABS | 56TABS | 28233 | 20th April 2026 | NORGINE | 13-Mar-26 | 20-May-26 | Manufacturing delay | ISOSORBIDE MONONITRATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ENDOXANA 1G PDR FOR SOLN/INJ | 1VIAL | 1st June 2026 | BAXTER | 27-Apr-26 | 20-May-26 | Manufacturing delay | CYCLOPHOSPHAMIDE | As per HPRA | |||
| EPILIM CHRONO 200MG PRO REL TABS | 30TABS | 37038 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPILIM CHRONO 300MG PRO REL TABS | 30TABS | 37039 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPILIM CHRONOSPHERE 100MG PRO REL GRAN | 30SACH | 23503 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPILIM CHRONOSPHERE 250MG PRO REL GRAN | 30SACH | 23516 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPLERENONE ROWEX 25MG FC TABS | 28TABS | 13175 | No date provided | ROWA | 27-Feb-26 | 20-May-26 | Currently queued for release in Lek | EPLERENONE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EPLERENONE VIATRIS 25MG FC TABS | 28TABS | 36897 | 20th July 2026 | VIATRIS | 22-Apr-26 | 20-May-26 | Unexpected increase in demand | EPLERENONE | As per Viatris. Short since Dec 25 | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EPORATIO 1000 IU/0.5ML SOLN FOR INJ PFS | 6SYR | 88474 | May-26 | TEVA | 27-Feb-26 | 20-May-26 | Manufacturing delay | EPOETIN THETA | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EPORATIO 10000 IU/1ML SOLN FOR INJ PFS | 6SYR | 88479 | Jun-26 | TEVA | 28-Apr-26 | 20-May-26 | Manufacturing delay | EPOETIN THETA | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EPORATIO 2000 IU/0.5ML SOLN FOR INJ PFS | 6SYR | 88475 | Back In Stock | TEVA | 01-May-26 | 22-May-26 | 21-May-26 | Manufacturing delay | EPOETIN THETA | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ERYTHROCIN 500MG TABS | 100TABS | 64076 | OOS expected early June 2026. No confirmed resupply timeline at present, | ADVANZ | 20-Mar-26 | 20-May-26 | Manufacturing issue | ERYTHROMYCIN | As per Advanz | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ESCITALPRO 15MG FC TABS ESCITALOPRAM | 28TABS | 13125 | Sep-26 | VIATRIS | 16-Mar-26 | 20-May-26 | Manufacturing delay | ESCITALOPRAM | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ESOMEPRAZOLE TILLO 40MG PDR SOLN/INJ/INF | 10VIAL | 15th June 2026 | AZURE | 01-May-26 | No reason provided | ESOMEPRAZOLE | As per HPRA | ||||
| ESTRADOT 100MCG/24HRS TRANSDERMAL PATCH | 8PATCH | 47415 | Awaiting further confirmation on allocation. | SANDOZ | 27-Mar-26 | 20-May-26 | Manufacturing delay | ESTRADIOL | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| ESTRADOT 37.5MCG/24HRS TRANSDERMAL PATCH | 8PATCH | 68314 | Awaiting further confirmation on allocation. | SANDOZ | 16-Apr-26 | 20-May-26 | No reason provided | ESTRADIOL | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| ESTRADOT 50MCG/24HRS TRANSDERMAL PATCH | 8PATCH | 57226 | Awaiting further confirmation on allocation. | SANDOZ | 16-Apr-26 | 20-May-26 | No reason provided | ESTRADIOL | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| ESTRADOT 75MCG/24HRS TRANSDERMAL PATCH | 8PATCH | 48323 | Awaiting further confirmation on allocation. | SANDOZ | 19-Feb-26 | 20-May-26 | No reason provided | ESTRADIOL | As per Rowa. | EMP reimbursed for duration of HPRA registered shortage | |
| ETORICOXIB 30MG FC TABS | 28TABS | 36842 | 26th July 2026 | VIATRIS | 24-Apr-26 | 20-May-26 | Manufacturing delays | ETORICOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ETORICOXIB TEVA 30MG FC TABS | 28TABS | 36884 | TBC | TEVA | 24-Nov-25 | 20-May-26 | Manufacturing delay | ETORICOXIB | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ETORICOXIB TEVA 60MG FC TABS | 28TABS | 36885 | OOS expected 27th May - 21st September 2026 | TEVA | 14-May-26 | 22-May-26 | Manufacturing delay | ETORICOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EUCARDIC 12.5MG TABS | 28TABS | 24256 | Jul-26 | ATHENA | 05-Mar-26 | 22-May-26 | No reason provided | CARVEDILOL | As per Athena | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EVISTA 60MG FC TABS BMODESTO | 28TABS | 67158 | Unable to provide date | BMODESTO | 03-Feb-26 | 20-May-26 | Company unable to source this product | RALOXIFENE | As per BModesto | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EZETIMIBE/SIMVASTATIN CLONMEL 10/10MG TA | 28TABS | 37024 | End May 2026 | CLONMEL | 13-Apr-26 | 22-May-26 | No reason provided | EZETIMIBE/SIMVASTATIN | As per Clonmel. HPRA shows 20.05.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EZETIMIBE/SIMVASTATIN CLONMEL 10/20MG TA | 28TABS | 37025 | End May 2026 | CLONMEL | 24-Mar-26 | 22-May-26 | No reason provided | EZETIMIBE/SIMVASTATIN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EZETIMIBE/SIMVASTATIN CLONMEL 10/80MG TA | 28TABS | 37027 | Back In Stock | CLONMEL | 24-Mar-26 | 22-May-26 | 22-May-26 | No reason provided | EZETIMIBE/SIMVASTATIN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| EZETIMIBE/SIMVASTATIN TEVA 10/40MG TABS | 30TABS | 37314 | 29th June 2026 | TEVA | 01-May-26 | 22-May-26 | Manufacturing delay | EZETIMIBE/SIMVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EZETROL 10MG TABS IMED | 30TABS | 67078 | No return date | IMED | 20-Jan-26 | 20-May-26 | Europe wide shortage | EZETIMIBE | As per IMED | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EZETROL 10MG TABS PCO | 28TABS | 23275 | Intermittent supply - Limited supply due as at 22.05.26 | PCO | 20-Jan-26 | 22-May-26 | No reason provided | EZETIMIBE | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FAMCICLOVIR TEVA 250MG FC TABS | 15TABS | 66157 | Jun-26 | TEVA | 08-May-25 | 20-May-26 | No reason provided | FAMCICLOVIR | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FAMOTIDINE CLONMEL 40MG FC TABS | 30TABS | 44453 | Back In Stock | CLONMEL | 13-Apr-26 | 22-May-26 | 22-May-26 | No reason provided | FAMOTIDINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| FASLODEX 250MGSOLN FOR INJ PFS PCO | 2SYR | 88793 | Unable to provide date | PCO | 20-Apr-26 | 20-May-26 | Unable to source stock at a workable price | FULVESTRANT | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FASTURTEC 1.5MG/ML PDR+SOLV/SOL/INF 1ML | 3VIAL | 1st June 2026 | SANOFI AVE | 05-May-26 | 20-May-26 | Managing remaining stocks until next resupply | RASBURICASE | As per Sanofi. HPRA shows 30.06.26 return date | |||
| FASTURTEC 1.5MG/ML PDR+SOLV/SOL/INF 5ML | 1VIAL | 25th May 2026 | SANOFI AVE | 12-May-26 | 20-May-26 | Managing remaining stocks until next resupply | RASBURICASE | As per Sanofi. HPRA shows 27.05.26 return date | |||
| FESOTERODINE ACCORD 8MG PRO REL TABS | 28TABS | 66940 | TBC | ACCORD HC | 05-Feb-26 | 20-May-26 | Manufacturing delay | FESOTERODINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FINGOLIMOD ACCORD 0.5MG HARD CAPS | 28CAPS | 89223 | TBC | ACCORD HC | 17-Feb-25 | 20-May-26 | Manufacturing delay | FINGOLIMOD | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FINGOLIMOD CLONMEL 0.5MG HARD CAPS | 28CAPS | 89398 | Mid August 2026 | CLONMEL | 19-Dec-25 | 22-May-26 | Manufacturing delay | FINGOLIMOD | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLECAINIDE 100MG TABS | 60TABS | 26080 | Jul-26 | TEVA | 05-Sep-25 | 21-May-26 | Manufacturing delay | FLECAINIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLECAINIDE 50MG TABS | 60TABS | 26072 | Nov-26 | TEVA | 06-May-25 | 21-May-26 | Manufacturing delay | FLECAINIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLUCILLIN 250MG CAPS FLUCLOXACILLIN | 100CAPS | 25194 | 31st July 2026 | PINEWOOD | 08-Oct-25 | 20-May-26 | Manufacturing delay | FLUCLOXACILLIN | As per HRPA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLUCILLIN 250MG CAPS FLUCLOXACILLIN | 500CAPS | 24821 | 31st July 2026 | PINEWOOD | 08-Oct-25 | 20-May-26 | Manufacturing delay | FLUCLOXACILLIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLUCONAZOLE 200MG HARD CAPS | 7CAPS | 25107 | Back In Stock | ACCORD HC | 05-Feb-26 | 22-May-26 | 22-May-26 | Manufacturing delay | FLUCONAZOLE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| FLUDARABINE PHOSPHATE 25MG/ML 2ML POA | 1VIAL | Back In Stock | ACCORD HC | 19-Aug-24 | 22-May-26 | 22-May-26 | Unexpected increased demand | FLUDARABINE | As per Accord | ||
| FOLINIC ACID 10MG/ML SOLN/ INJ/INF 5ML | 1VIAL | Not relaunched to date | CARAGEN | 05-Dec-25 | 21-Apr-26 | No reason provided | FOLINIC ACID | As per Caragen | |||
| FOLINIC ACID 10MG/ML SOLN/INJ/INF 50ML | 1VIAL | Not relaunched to date | CARAGEN | 05-Dec-25 | 21-Apr-26 | No reason provided | FOLINIC ACID | As per Caragen | |||
| FOSAVANCE 70MG/5600IU TABS | 4TABS | 75382 | 7th May 2026 | ORGANON | 27-Mar-26 | 20-May-26 | Unexpected increased demand | ALENDRONIC AC/COLECALCIFE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FUCITHALMIC 10MG/G VISCOUS EYE DROP SUSP | 5G | 26441 | No confirmed timeline | ADVANZ | 13-Sep-19 | 20-May-26 | Long term manufacturing issue | FUSIDIC ACID | Contact Advanz Customer Service 1890 252 474 for further info. HPRA shows 31.10.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FUROSEMIDE 40MG TABS | 500TABS | 74551 | TBC | CLONMEL | 22-May-26 | No reason provided | FUROSEMIDE | As per Clonmel | |||
| GABIN 100MG HARD CAPS GABAPENTIN | 100CAPS | 76704 | No date provided | ROWA | 08-May-26 | 22-May-26 | Stock is currently in UD, awaiting test results | GABAPENTIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| GAMANIL 70MG TABS | 56TABS | 25143 | Aug-27 | ZENTIVA | 18-Dec-23 | 20-May-26 | Very complex product transfer resulting in a number of delays. | LOFEPRAMINE | As per Zentiva | EMP reimbursed for duration of HPRA registered shortage | |
| GASTROGRAFIN ORAL AND RECTAL SOLUTION | 100ML | 31st May 2027 | BAYER | 10-Mar-26 | 16-Mar-26 | Quality issue | SOD AMIDOTRI/MEGLUM AMIDO | As per HPRA | |||
| GEODON 80MG HARD CAPS | 60CAPS | 36018 | 20th July 2026 | VIATRIS | 07-May-26 | 22-May-26 | Manufacturing delay | ZIPRASIDONE | As per Viattris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| GEROQUEL 100MG FC TABS QUETIAPINE | 60TABS | 46081 | 31st August 2026 | VIATRIS | 16-Feb-26 | 20-May-26 | Unexpected increased demand | QUETIAPINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| GEROQUEL 25MG FC TABS QUETIAPINE | 60TABS | 46080 | 31st July 2026 | VIATRIS | 17-Feb-26 | 20-May-26 | Unexpected increased demand | QUETIAPINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| GLYPRESSIN IMG PDR + SOLV FOR SOLN/ INJ | 5AMP | 8th June 2026 | FERRING | 08-May-26 | 25-May-26 | Unexpected increased demand | TERLIPRESSIN | As per HPRA | |||
| GOLDEN EYE 0.15% OINTMENT | 5G | Jan-27 | CAM HC SUP | 29-Aug-25 | 06-Oct-25 | Manufacturing delays | DIBROMPROPAMIDINE | As per HPRA | |||
| GRANPIDAM 20MG FC TABS | 90TABS | 88759 | w/e 29th May 2026 | ACCORD HC | 20-Apr-26 | 22-May-26 | In transit | SILDENAFIL | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| GREPID 75MG FC TABS CLOPIDOGREL | 28TABS | 27519 | Early July 2026 | PHARMATHEN | 20-Mar-25 | 20-May-26 | Shipping delay / distribution issue | CLOPIDOGREL | As per Pinewood. HPRA shows 31.07.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| HYPNOVEL 10MG/2ML SOLN FOR INJ | 10AMP | 28825 | 26th May 2026 | ATHENA | 27-Apr-26 | 25-May-26 | Manufacturing delay | MIDAZOLAM | As per Athena | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| HYTRIN 2MG TABS | 28TABS | 27650 | No confirmed timeline | ADVANZ | 10-Mar-23 | 20-May-26 | Delivery delay | TERAZOSIN | As per Advanz. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IBANDRONIC ACID MYLAN 150MG FC TABS | 1TABS | 14041 | No back in stock date available at the moment | VIATRIS | 03-Sep-25 | 20-May-26 | Unexpected increased demand | IBANDRONIC ACID | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IBANDRONIC ACID TEVA 150MG FC TABS | 1TABS | 16130 | TBC | TEVA | 07-Dec-23 | 20-May-26 | No reason provided | IBANDRONIC ACID | As per Teva (HPRA shows 01.12.26 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IBUPROFEN 200MG FC TABS | 100TABS | 67172 | Awaiting return date | ACCORD HC | 16-Apr-26 | 20-May-26 | Manufacturing delay | IBUPROFEN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IBUPROFEN 200MG FC TABS | 24TABS | 8th May 2026 | CHEFARO | 13-Jan-26 | No reason provided | IBUPROFEN | As per HPRA | ||||
| IMDUR 60MG PRO REL TABS | 28TABS | 31410 | Pending | NAVAMEDIC | 29-Sep-23 | 20-May-26 | Unexpected increase in demand | ISOSORBIDE MONONITRATE | As per HPRA. 08.10.25 Navamedic advised they have no estimate of re-supply date for Imdur in Ireland | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INDORAMIN 20MG FC TABS | 60TABS | 76003 | Jul-26 | CHEMIDEX | 20-Jan-26 | 20-May-26 | Manufacturing delay | INDORAMIN | As per HPRA. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INEGY 10MG/20MG TABS | 28TABS | 29845 | 25th May 2026 | ORGANON | 23-Feb-26 | 20-May-26 | Manufacturing delay | EZETIMIBE/SIMVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INSUL LEVEMIR FLEXPEN 100 UNITS/ML BMODE | 5PENS | 67213 | Unable to provide date | BMODESTO | 12-Mar-26 | 20-May-26 | Company trying to source supply | INSULIN DETEMIR | As per BModesto | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INSUL LEVEMIR PENFILL100 UNIT/ML CTG PCO | 5CARTRIDG | 63005 | Unable to provide date | PCO | 23-Jan-26 | 22-May-26 | PCO have had no supply for several months | INSULIN DETEMIR | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INSUL NOVORAPID PENFILL 100 U/ML CTG | 5CARTRIDG | 63121 | On Allocation | NOVO NRDSK | 06-Mar-20 | 20-May-26 | INSULIN ASPART | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| IPRATROPIUM STERI-NEB 250MCG/ML NEB SOLN | 20NEB | 45080 | 2026 | TEVA | 01-Aug-24 | 20-May-26 | Manufacturing delay | IPRATROPIUM | As per Teva (HPRA shows 24/04/26 return date) | EMP reimbursed for duration of HPRA registered shortage | |
| IRBESARTAN CLONMEL 300MG FC TABS | 28TABS | 54342 | End May 2026 | CLONMEL | 13-Feb-26 | 22-May-26 | Manufacturing delay | IRBESARTAN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IRINOTECAN HCL 20MG/ML CONC/SOLN/INF 2ML | 1VIAL | May-26 | TEVA | 25-Sep-25 | 27-Apr-26 | Manufacturing delay | IRINOTECAN | As per Teva | |||
| IRUXOL MONO 1.2 U/G OINTMENT | 20G | 29297 | Pending | S&NEPHEW | 31-Mar-26 | 20-May-26 | Manufacturing delay | COLLAGENASE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ISOMEL 60MG SR TABS ISOSORBIDE MONO | 28TABS | 31672 | Early June 2026 | CLONMEL | 03-Sep-25 | 22-May-26 | Unexpected increased demand | ISOSORBIDE MONONITRATE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IVABRADINE KRKA 5MG FC TABS | 56TABS | 42790 | 24th July 2026 | KRKA PHARM | 23-Mar-26 | 20-May-26 | No reason provided | IVABRADINE | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| KAY-CEE-L 7.5% SYRUP | 500ML | 29769 | Awaiting update | SYRI PHARM | 04-Mar-24 | 20-May-26 | Currently under testing and regulatory approval | POTASSIUM CHLORIDE | As per Syri Pharma | EMP reimbursed for duration of HPRA registered shortage | |
| LARIG 100MG DISP TABS LAMOTRIGINE | 56TABS | 30664 | Early July 2026 | ROWA | 14-May-26 | 25-May-26 | Delayed delivery | LAMOTRIGINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LENALIDOMIDE ROWEX 25MG HARD CAPS | 21CAPS | 89149 | Possibly June 2026 | ROWA | 24-Apr-26 | 20-May-26 | Delayed delivery | LENALIDOMIDE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LETROZOLE 2.5MG FC TABS | 28TABS | 24520 | Jul-26 | ACCORD HC | 05-Feb-26 | 20-May-26 | Unexpected increased demand | LETROZOLE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LETROZOLE TEVA 2.5MG FC TABS | 30TABS | 24517 | Sep-26 | TEVA | 22-Apr-26 | 20-May-26 | Manufacturing delay | LETROZOLE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LETZO 2.5MG FC TABS LETROZOLE | 30TABS | 24525 | Awaiting further update | ROWA | 21-Nov-25 | 20-May-26 | Stock going for shipment prep | LETROZOLE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LEVETIRACETAM CLONMEL 1000MG FC TABS | 60TABS | 51419 | Mid June 2026 | CLONMEL | 15-Jul-25 | 22-May-26 | No reason provided | LEVETIRACETAM | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LEVOTHYROXINE TEVA 100MCG TABS | 28TABS | 34533 | 26th June 2026 (limited stock remaining as at 08.05.26) | TEVA | 27-Feb-26 | 20-May-26 | Manufacturing delay | LEVOTHYROXINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LEVOTHYROXINE TEVA 50MCG TABS | 28TABS | 34532 | 26th June 2026 | TEVA | 08-May-26 | 25-May-26 | Manufacturing delay | LEVOTHYROXINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LIBRIUM 10MG HARD CAPS | 100CAPS | 31550 | 31st July 2026 | VIATRIS | 17-Feb-26 | 20-May-26 | API Shortage / unavailability | CHLORDIAZEPOXIDE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LIBRIUM 5MG HARD CAPS | 100CAPS | 72099 | 31st July 2026 | VIATRIS | 13-Apr-26 | 20-May-26 | API Shortage / unavailability | CHLORDIAZEPOXIDE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LIXIANA 15MG FC TABS | 10TABS | 36930 | 5th June 2026 | DAIICI SAN | 27-Feb-26 | 20-May-26 | Manufacturing delay | EDOXABAN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LOGYNON TABS | 21TABS | 77577 | 8th June 2026 | BAYER | 04-May-26 | 22-May-26 | Manufacturing delay | LEVONORGESTREL/ETHINYLEST | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LORAT 10MG TABS LORATADINE | 30TABS | 32012 | End June 2026 | ROWA | 14-May-26 | 25-May-26 | Production delay | LORATADINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LYCLEAR 5% DERMAL CREAM | 30G | 32292 | On Allocation | GSK MED | 03-May-24 | 20-May-26 | Supply constrained due to increased demand | PERMETHRIN | As per GSK | EMP reimbursed for duration of HPRA registered shortage | |
| MEGACE 160MG TABS | 30TABS | 33472 | 1st July 2026 | BAUSCH HEA | 18-Mar-26 | 20-May-26 | Manufacturing delay | MEGESTROL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MEMANTINE ACCORD 10MG FC TABS | 28TABS | 32559 | Jun-26 | ACCORD HC | 06-Feb-26 | 20-May-26 | Manufacturing delay | MEMANTINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MEMANTINE ACCORD 10MG FC TABS | 56TABS | 32560 | Jul-26 | ACCORD HC | 06-Feb-26 | 20-May-26 | Manufacturing delay | MEMANTINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MEMANTINE CLONMEL 10MG FC TABS | 56TABS | 31123 | End June 2026 | CLONMEL | 21-May-26 | 22-May-26 | Manufacturing delay | MEMANTINE | As per Clonmel | ||
| MENTHOLATUM DEEP HEAT SPRY CUT SPRAY SOL | 150ML | 30th June 2026 | MENTHOLATM | 08-Jan-25 | 18-Jun-25 | Manufacturing delay | As per HPRA | ||||
| MEROPENEM AUROBINDO 1G PDR/SOLN/INJ/INF | 10VIAL | Pending | ATHLONE PH | 15-Jan-26 | 04-Mar-26 | Quality issue | MEROPENEM | As per HPRA. | |||
| METFORMIN HCL 500MG/5ML ORAL SOLN | 150ML | 33690 | 31st May 2026 | ROSEMONT | 09-Apr-26 | 20-May-26 | Quality issue | METFORMIN | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| METFORMIN TEVA 500MG FC TABS | 84TABS | 36825 | OOS expected 2nd - 8th June 2026 | TEVA | 19-May-26 | Manufacturing delay | METFORMIN | As per HPRA | |||
| METHADONE MIXTURE DTF SF 1MG/ML ORAL SOL | 500ML | 9810 | In Stock | MARTINDALE | 06-May-26 | 25-May-26 | 25-May-26 | Manufacturing delay | METHADONE | No longer on HPRA list | Back in stock |
| MIDON 2.5MG TABS | 100TABS | 34444 | 30th November 2026 | ATHENA | 19-May-26 | 25-May-26 | Unexpected increased demand | MIDODRINE | As per HPRA | ||
| MIRAP DISTAB 15MG ORODISP TABS MIRTAZAPI | 30TABS | 33549 | No date provided | ROWA | 08-May-26 | 22-May-26 | Current stock expiring 07.2026, Awaiting confirmation of next delivery Artwork needs to be finalised | MIRTAZAPINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MIVACRON 2MG/ML SOLN FOR INJ 5ML | 5AMP | 8th September 2026 | ASPEN | 05-Jan-26 | Manufacturing delay | MIVACURIUM | As per HPRA | ||||
| MONTELUKAST PAEDIATRIC 4MG CHEWABLE TABS | 28TABS | 45130 | TBC | ACCORD HC | 16-Sep-24 | 20-May-26 | Ongoing QA issue | MONTELUKAST | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MONTELUKAST PAEDIATRIC 5MG CHEWABLE TABS | 28TABS | 45131 | TBC | ACCORD HC | 12-Mar-26 | 20-May-26 | Manufacturing delay | MONTELUKAST | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MORPHINE SULPHATE 10MG/ML SOLN/INJ 1ML | 10AMP | Not relaunched to date | CARAGEN | 29-May-25 | 21-Apr-26 | No reason provided | MORPHINE SULFATE | As per Caragen | |||
| MORPHINE SULPHATE 30MG/ML SOLN/INJ 1ML | 10AMP | Not relaunched to date | CARAGEN | 29-May-25 | 21-Apr-26 | No reason provided | MORPHINE SULFATE | As per Caragen | |||
| MYCOBUTIN 150MG CAPS | 30CAPS | 64723 | Pending | PFIZER | 27-Apr-26 | 20-May-26 | API shortage / unavailability | RIFABUTIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NALTREXONE HYDROCHLORIDE 50MG FC TABS | 28TABS | 15085 | TBC | ACCORD HC | 19-Feb-26 | 20-May-26 | Manufacturing delay | NALTREXONE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NARAVERG 2.5MG FC TABS | 12TABS | 46643 | Jun-26 | TEVA | 19-Mar-26 | 20-May-26 | No reason provided | NARATRIPTAN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NEBIVOLOL ACCORD 5MG TABS | 28TABS | 66814 | Jun-26 | ACCORD HC | 13-Mar-26 | 20-May-26 | Unexpected increased demand | NEBIVOLOL | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NEBIVOLOL TEVA 5MG TABS | 28TABS | 35690 | OOS expected 27th May - 5th June 2026 | TEVA | 18-May-26 | 20-May-26 | Manufacturing delay | NEBIVOLOL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NEUROSTIL 100MG HARD CAPS GABAPENTIN | 100CAPS | 36772 | Jul-26 | TEVA | 09-Apr-26 | 20-May-26 | Manufacturing delay | GABAPENTIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NEUROSTIL 300MG HARD CAPS GABAPENTIN | 100CAPS | 36783 | OOS expected 1st June - 1st July 2026 | TEVA | 19-May-26 | Manufacturing delay | GABAPENTIN | As per HPRA | |||
| NEUROSTIL 400MG CAPS HARD GABAPENTIN | 100CAPS | 36794 | Jun-26 | TEVA | 25-Nov-25 | 20-May-26 | Manufacturing delay | GABAPENTIN | As per Teva (HPRA shows 01.06.226 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NIMBEX 2MG/ML SOLN FOR INJ/INF 2.5ML | 5AMP | Return date pending | ASPEN | 27-Apr-26 | 01-May-26 | Quality issue | CISATRACURIUM | As per HPRA | |||
| NIMOTOP 0.2MG/ML CONC FOR SOLN/INF 50ML | 5VIAL | In Stock | LAB X.O | 20-Feb-26 | 25-May-26 | 25-May-26 | Regulatory issue | NIMODIPINE | No longer on HPRA list | ||
| NIQUITIN MINI 2MG MINT LOZENGES | 100LOZ | 66866 | 15th June 2026 | PERRIGO | 13-Feb-26 | 20-May-26 | Shipping delay / distribution issue | NICOTINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NIQUITIN MINI 2MG MINT LOZENGES | 60LOZ | 15th June 2026 | PERRIGO | 13-Feb-26 | 13-Apr-26 | Shipping delay / distribution issue | NICOTINE | As per HPRA | |||
| NIQUITIN MINI 4MG MINT LOZENGES | 100LOZ | 66867 | 30th April 2026 | PERRIGO | 10-Mar-26 | 20-May-26 | Shipping delay / distribution issue | NICOTINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NIQUITIN MINI 4MG MINT LOZENGES | 60LOZ | 31st May 2026 | PERRIGO | 24-Feb-26 | 09-Mar-26 | Shipping delay / distribution issue | NICOTINE | As per HPRA | |||
| NORADRENALINE 1:1000 CONC/SOLN/INF 2ML | 5AMP | 15th June 2026 | PFIZER | 21-Apr-26 | 05-May-26 | Manufacturing delay | NOREPINEPHRINE | As per HPRA | |||
| NORIDAY 350MCG TABS | 28TABS | 62375 | 7th June 2026 | PFIZER | 01-May-26 | 22-May-26 | Quality issue | NORETHISTERONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NORTEM 20MG TABS TEMAZEPAM | 28TABS | 19427 | Jun-26 | TEVA | 20-Mar-26 | 20-May-26 | Manufacturing delay | TEMAZEPAM | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NOTIABOLFEN XL 150MG PRO REL TABS | 60TABS | 31787 | TBC | ACCORD HC | 04-Feb-26 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| NOTIABOLFEN XL 200MG PRO REL TABS | 60TABS | 32632 | TBC | ACCORD HC | 21-Jul-25 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| NOTIABOLFEN XL 300MG PRO REL TABS | 60TABS | 32743 | TBC | ACCORD HC | 21-Jul-25 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| NOTIABOLFEN XL 400MG PRO REL TABS | 60TABS | 32796 | TBC | ACCORD HC | 21-Jul-25 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| NOTIABOLFEN XL 50MG PRO REL TABS | 60TABS | 32604 | TBC | ACCORD HC | 05-Aug-25 | 20-May-26 | Manufacturer delay | QUETIAPINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| OLANZAPINE 10MG FC TABS | 28TABS | 32926 | Mid June 2026 | CLONMEL | 22-May-26 | No reason provided | OLANZAPINE | As per Clonmel | |||
| OLANZAPINE 2.5MG FC TABS | 28TABS | 32923 | Mid June 2026 | CLONMEL | 10-Feb-26 | 22-May-26 | No reason provided | OLANZAPINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLANZAPINE ACCORD 10MG FC TABS | 28TABS | 42313 | TBC | ACCORD HC | 19-Feb-26 | 20-May-26 | Manufacturing delay | OLANZAPINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLANZAPINE ACCORD 2.5MG FC TABS | 28TABS | 42310 | TBC | ACCORD HC | 12-Mar-26 | 20-May-26 | Manufacturing delay | OLANZAPINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLANZAPINE TEVA 10MG ORODISP TABS | 28TABS | 32967 | 25th July 2026 | TEVA | 08-May-26 | 22-May-26 | Manufacturing delay | OLANZAPINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLANZAPINE VIATRIS 5MG FC TABS | 28TABS | 32951 | 1st March 2027 | VIATRIS | 08-May-26 | 22-May-26 | Manufacturing delay | OLANZAPINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLANZAPINE VIATRIS 7.5MG FC TABS | 56TABS | 32952 | 16th June 2026 | VIATRIS | 26-Nov-25 | 20-May-26 | Manufacturing delay | OLANZAPINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLMESARTAN MEDOXOMIL 10MG FC TABS | 28TABS | 37623 | TBC | ACCORD HC | 22-Jul-25 | 22-May-26 | Unexpected increased demand | OLMESARTAN | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLMESARTAN MEDOXOMIL 20MG FC TABS | 28TABS | 37624 | Back In Stock | ACCORD HC | 06-Feb-26 | 22-May-26 | 22-May-26 | Unexpected increased demand | OLMESARTAN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| OLMESARTAN ROWEX 10MG FC TABS | 28TABS | 34856 | No date provided | ROWA | 09-Jan-26 | 20-May-26 | Being shipped from site on 11.05.26 | OLMESARTAN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLMESARTAN/AMLODIPINE HCTZ 40/10/12.5MG | 28TABS | 37408 | Mid June 2026 | CLONMEL | 22-May-26 | No reason provided | OLMESARTAN/AMLODIPIN/HCTZ | As per Clonmel | |||
| ONDANSETRON 4MG FC TABS | 30TABS | 55360 | Jul-26 | TEVA | 26-Mar-26 | 20-May-26 | Manufacturing delay | ONDANSETRON | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ONDANSETRON 8MG FC TABS | 10TABS | 55361 | Aug-26 | TEVA | 11-Nov-25 | 20-May-26 | Manufacturing delay | ONDANSETRON | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OXALIPLATIN 5MG/ML CONC/SOLN/INF 10ML | 1VIAL | TBC | ACCORD HC | 13-Mar-26 | 27-Mar-26 | Manufacturing delay | OXALIPLATIN | As per Accord | |||
| OXYBUTYNIN HYDROCHLORIDE 2.5MG TABS | 84TABS | 32333 | Jul-26 | ACCORD HC | 26-Jun-25 | 20-May-26 | Manufacturing delay | OXYBUTYNIN | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| OXYBUTYNIN HYDROCHLORIDE 5MG TABS | 84TABS | 32334 | Aug-26 | ACCORD HC | 26-Jun-25 | 20-May-26 | Manufacturing delay | OXYBUTYNIN | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| OXYNORM 10MG/ML SOLN FOR INJ 1ML | 5AMP | 59017 | 25th May 2026 | MUNDIPHARM | 27-Apr-26 | 20-May-26 | Shipping delay / distribution issue | OXYCODONE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| OXYNORM 10MG/ML SOLN FOR INJ 2ML | 5AMP | 59073 | 25th May 2026 | MUNDIPHARM | 27-Apr-26 | 20-May-26 | Shipping delay / distribution issue | OXYCODONE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| OZALIN 2MG/ML ORAL SOLN SINGLE DOSE 5ML | 10AMP | 31st December 2027 | NORDICPHAR | 07-Apr-26 | Regulatory issue | MIDAZOLAM | As per HPRA | ||||
| PABRINEX IV HIGH POTENCY CONC/SOLN/INF | 12AMP | 31st July 2026 | GRUNENTHAL | 07-May-24 | 19-Feb-26 | Manufacturing issues | VITAMIN B/VITAMIN C | As per HPRA | |||
| PACLITAXEL 6MG/ML CONCSOLNINF 50ML | 1VIAL | Back In Stock | ACCORD HC | 25-Aug-25 | 22-May-26 | 22-May-26 | Manufacturing delay | PACLITAXEL | As per Accord | ||
| PALEXIA 20MG/ML ORAL SOLN | 200ML | 18245 | 12th June 2026 | GRUNENTHAL | 28-Apr-26 | 20-May-26 | Manufacturing delay | TAPENTADOL | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| PALMEUX 100MG PRO REL SUSP FOR INJ PFS | 1SYR | 67003 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 20-May-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows March 2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PALMEUX 150MG PRO REL SUSP FOR INJ PFS | 1SYR | 67004 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 20-May-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows March 2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PALMEUX 50MG PRO REL SUSP FOR INJ PFS | 1SYR | 67001 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 20-May-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows March 2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PALMEUX 75MG PRO REL SUSP FOR INJ PFS | 1SYR | 67002 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 20-May-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows March 2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PARACETAMOL 500MG FC TABS | 24TABS | 31st May 2026 | PERRIGO | 24-Feb-26 | 09-Mar-26 | Unexpected increased demand | PARACETAMOL | As per HPRA | |||
| PARALIEF 500MG EFF TABS PARACETAMOL | 12TABS | TBC | CLONMEL | 11-May-26 | 22-May-26 | Manufacturing delay | PARACETAMOL | As per Clonmel | |||
| PARALIEF 500MG EFF TABS PARACETAMOL | 24TABS | TBC | CLONMEL | 12-May-26 | 22-May-26 | Manufacturing delay | PARACETAMOL | As per Clonmel | |||
| PARVOLEX 200MG/ML CONC FOR SOLN FOR INF | 10AMP | In Stock | PHOENIX | 08-May-26 | 25-May-26 | 25-May-26 | Manufacturing delay | ACETYLCYSTEINE | No longer on HPRA list | ||
| PEMETREXED ACCORD 25MG/ML CONC INF 34ML | 1VIAL | TBC | ACCORD HC | 06-Feb-26 | 27-Mar-26 | Manufacturing delay | PEMETREXED | As per Accord | |||
| PENTASA SACHET 2G PRO REL GRANULES | 60SACH | 59657 | 31st May 2026 | FERRING | 20-Apr-26 | 20-May-26 | Unexpected increased demand | MESALAZINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL TOS/AMLODIPINE TEVA 5MG/5MG | 30TABS | 36844 | OOS expected 31st May - 12th October 2026 | TEVA | 15-May-26 | Manufacturing delay | PERINDOPRIL TOSIL/AMLODIP | As per HPRA | |||
| PERINDOPRIL TOS/INDAPAMIDE TEVA 10/2.5MG | 30TABS | 39122 | Jul-26 | TEVA | 20-Mar-26 | 20-May-26 | Manufacturing delay | PERINDOPRIL TOSIL/INDAPAM | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL TOS/INDAPAMIDE TEVA 5/1.25MG | 30TABS | 39115 | Jul-26 | TEVA | 05-Jan-26 | 20-May-26 | Manufacturing delay | PERINDOPRIL TOSIL/INDAPAM | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PINACORT 3MG MOD REL HARD CAPS | 100CAPS | 67118 | Pending | PINEWOOD | 03-Nov-25 | 20-May-26 | No reason provided | BUDESONIDE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PLERIXAFOR ACCORD 20MG/ML SOLN/INJ 1.2ML | 1VIAL | TBC | ACCORD HC | 23-Feb-26 | 27-Mar-26 | No reason provided | PLERIXAFOR | As per Accord | |||
| PONSTAN 250MG CAPS | 100CAPS | 41580 | No return date. | CHEMIDEX | 17-Oct-25 | 20-May-26 | No reason provided | MEFENAMIC ACID | As per Allphar | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PONSTAN 250MG CAPS | 500CAPS | 41572 | No return date. | CHEMIDEX | 17-Oct-25 | 20-May-26 | No reason provided | MEFENAMIC ACID | As per Allphar | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PRASUGREL VIATRIS 10MG FC TABS | 28PACK | 37407 | 31st July 2026 | VIATRIS | 15-Sep-25 | 20-May-26 | Manufacturing delay | PRASUGREL | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PRAVITIN 10MG TABS PRAVASTATIN | 30TABS | 60501 | End May 2026 | ROWA | 21-Apr-26 | 25-May-26 | Production delays | PRAVASTATIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREDNISOLONE 1MG TABS | 250TABS | 78304 | TBC | CLONMEL | 17-Jul-25 | 20-May-26 | Manufacturing delay | PREDNISOLONE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREDNISOLONE 5MG SOLUBLE TABS | 30TABS | 51269 | End June 2026 | ADVANZ | 10-Mar-23 | 20-May-26 | Delivery delay | PREDNISOLONE SODIUM PHOS | As per HPRA. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN ACCORD 200MG HARD CAPS | 84CAPS | 65390 | Jun-26 | ACCORD HC | 22-Jul-25 | 20-May-26 | No reason provided | PREGABALIN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN ACCORD 25MG HARD CAPS | 56CAPS | 65380 | Jun-26 | ACCORD HC | 22-Jul-25 | 20-May-26 | No reason provided | PREGABALIN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN ACCORD 300MG HARD CAPS | 56CAPS | 65392 | Jun-26 | ACCORD HC | 22-Jul-25 | 20-May-26 | No reason provided | PREGABALIN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN SANDOZ GMBH 100MG HARD CAPS | 84CAPS | 36949 | TBC | ROWA | 09-Jun-25 | 20-May-26 | Production delays | PREGABALIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN SANDOZ GMBH 200MG HARD CAPS | 84CAPS | 36952 | Awaiting further update | ROWA | 20-Mar-25 | 20-May-26 | Delay due to packing line adjustments | PREGABALIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN SANDOZ GMBH 75MG HARD CAPS | 56CAPS | 36948 | TBC | ROWA | 08-Apr-26 | 20-May-26 | Increase in sales | PREGABALIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN TEVA 100MG HARD CAPS | 84CAPS | 37003 | Jun-26 | TEVA | 12-Mar-26 | 20-May-26 | Manufacturing delay | PREGABALIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PROSTIN E2 1MG VAGINAL GEL | 1SYR | 1st September 2026 | PFIZER | 27-Mar-26 | API shortage / unavailability | DINOPROSTONE | As per HPRA | ||||
| PROSTIN E2 2MG VAGINAL GEL | 1SYR | 1st September 2026 | PFIZER | 27-Mar-26 | 20-Apr-26 | API shortages / unavailability | DINOPROSTONE | As per HPRA | |||
| QLAIRA FC TABS | 28TABS | 56907 | 9th June 2026 | BAYER | 01-May-26 | 22-May-26 | Manufacturing delay | ESTRADIOL/DIENOGEST | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| QUENTIAX SR 200MG PRO REL TAB QUETIAPINE | 60TABS | 71267 | 15th June 2026 | KRKA PHARM | 11-Nov-25 | 20-May-26 | No reason provided | QUETIAPINE | As per HPRA. | EMP reimbursed for duration of HPRA registered shortage | |
| QUENTIAX SR 300MG PRO REL TAB QUETIAPINE | 60TABS | 71270 | First week of July 2026 | KRKA PHARM | 03-Nov-25 | 20-May-26 | No reason provided | QUETIAPINE | As per KRKA. | EMP reimbursed for duration of HPRA registered shortage | |
| QUETEX XR 200MG PRO REL TABS | 60TABS | 45168 | Oct-26 | ROWA | 03-Feb-25 | 20-May-26 | Pharmathen supply issues | QUETIAPINE | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| QUETEX XR 300MG PRO REL TABS | 60TABS | 45169 | No stock in Q1, Q2 or Q3 - We will have to wait until Q4 allocation | ROWA | 14-Jun-24 | 20-May-26 | #NAME? | QUETIAPINE | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| QUETEX XR 50MG PRO REL TABS | 60TABS | 46021 | No stock in Q1, Q2 or Q3 - We will have to wait until Q4 allocation | ROWA | 26-Mar-25 | 20-May-26 | Pharmathen supply issues | QUETIAPINE | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| QUETIAPINE 200MG FC TABS | 60TABS | 46088 | No return date | ACCORD HC | 24-Feb-26 | 20-May-26 | No reason provided | QUETIAPINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| QUETIAPINE 300MG FC TABS | 60TABS | 46089 | No return date | ACCORD HC | 24-Feb-26 | 20-May-26 | No reason provided | QUETIAPINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| QUETIAPINE KRKA 300MG FC TABS | 60TABS | 46023 | End July 2026 | KRKA PHARM | 18-Feb-26 | 22-May-26 | No reason provided | QUETIAPINE | As per KRKA | EMP reimbursed for duration of HPRA registered shortage | |
| RAMIPRIL KRKA 1.25MG TABS | 30TABS | 50017 | Back In Stock | KRKA PHARM | 07-Apr-26 | 22-May-26 | 22-May-26 | Unexpected increased demand | RAMIPRIL | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| RINOZAL 5MG FC TABS LEVOCETIRIZINE | 30TABS | 77801 | TBC | CLONMEL | 11-Mar-26 | 22-May-26 | Regulatory issue | LEVOCETIRIZINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RISPEVA 1MG FC TABS RISPERIDONE | 20TABS | 45309 | Jul-26 | TEVA | 11-Feb-26 | 20-May-26 | No reason provided | RISPERIDONE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RIVAROXABAN ROWEX 10MG FC TABS | 28TABS | 67332 | TBC | ROWEX | 20-Mar-26 | 20-May-26 | Manufacturing delay | RIVAROXABAN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RIVAROXABAN VIATRIS 10MG FC TABS | 30TABS | 67376 | Back In Stock | VIATRIS | 20-Mar-26 | 25-May-26 | 22-May-26 | Quality issue | RIVAROXABAN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| RIVAROXABAN VIATRIS 15MG FC TABS | 28TABS | 67377 | Back In Stock | VIATRIS | 20-Mar-26 | 25-May-26 | 22-May-26 | Quality issue | RIVAROXABAN | As per Viattris | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| RIVAROXABAN VIATRIS 20MG FC TABS | 28TABS | 67378 | Back In Stock | VIATRIS | 20-Mar-26 | 25-May-26 | 22-May-26 | Quality issre | RIVAROXABAN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ROSUVASTATIN CLONMEL 20MG FC TABS | 28TABS | 62872 | Early June 2026 | CLONMEL | 22-May-26 | No reason provided | ROSUVASTATIN | As per Clonmel | |||
| ROSUVASTATIN VIATRIS 10MG FC TABS | 28TABS | 62866 | Sep-26 | VIATRIS | 01-Apr-26 | 20-May-26 | Manufacturing delay | ROSUVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ROSUVASTATIN VIATRIS 20MG FC TABS | 28TABS | 62867 | Sep-26 | VIATRIS | 01-Apr-26 | 20-May-26 | Manufacturing delay | ROSUVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ROWALIEF 500MG FC TABS PARACETAMOL | 300TABS | 68501 | Possibly End May 2026 | ROWA | 24-Dec-25 | 20-May-26 | Stock arriving 11th May, then testing should have results by end of month | PARACETAMOL | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SASTRAVI 150/37.5/200MG FC TABS | 100TABS | 13505 | Aug-26 | TEVA | 21-May-26 | No reason provided | LEVODOPA/CARBIDOPA/ENTACA | As per Teva | |||
| SAVLON ANTISEPTIC CREAM | 60G | TBC | CLONMEL | 14-Nov-25 | 16-Dec-25 | Manufacturing delay | CETRIMIDE/CHLORHEXIDINE | As per Clonmel | |||
| SERETRAL 100MG TABS SERTRALINE | 30TABS | 45478 | Jul-26 | TEVA | 27-Feb-26 | 20-May-26 | Manufacturing delay | SERTRALINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SERETRAL 50MG TABS SERTRALINE | 30TABS | 45449 | Jul-26 | TEVA | 25-Nov-25 | 20-May-26 | Manufacturing delay | SERTRALINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SERLAN TABS 50MG SERTRALINE | 28TABS | 78435 | Early June 2026 | ROWA | 20-Mar-26 | 20-May-26 | Manufacturing delay - API shortage | SERTRALINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SEROPIA XR 150MG PRO REL TABS QUETIAPINE | 60TABS | 46096 | End July 2026 | CLONMEL | 22-Oct-24 | 22-May-26 | No reason provided | QUETIAPINE | As per Clonmel | EMP reimbursed for duration of HPRA registered shortage | |
| SEROPIA XR 200MG PRO REL TABS QUETIAPINE | 60TABS | 46097 | End June 2026 | CLONMEL | 13-Apr-26 | 22-May-26 | No reason provided | QUETIAPINE | As per Clonmel | EMP reimbursed for duration of HPRA registered shortage | |
| SEROPIA XR 300MG PRO REL TABS QUETIAPINE | 60TABS | 46098 | Mid July 2026 | CLONMEL | 10-Jun-24 | 20-May-26 | No reason provided | QUETIAPINE | As per Clonmel (HPRA shows 31.07.26 return date) | EMP reimbursed for duration of HPRA registered shortage | |
| SEROPIA XR 400MG PRO REL TABS QUETIAPINE | 60TABS | 46099 | Back In Stock | CLONMEL | 10-Jan-25 | 22-May-26 | 22-May-26 | Manufacturing delay | QUETIAPINE | As per Clonmel | EMP reimbursed for duration of HPRA registered shortage |
| SEROPIA XR 50MG PRO REL TABS QUETIAPINE | 60TABS | 46095 | End July 2026 | CLONMEL | 13-Jan-25 | 22-May-26 | Manufacturing delay | QUETIAPINE | As per Clonmel | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 150MG PRO REL TABS ORIGINAL | 60TABS | No resupply date | ORIGINALIS | 18-Nov-25 | Low sales price in Ireland and demand | QUETIAPINE | As per Originals | ||||
| SEROQUEL XR 200MG PRO REL TABS | 60TABS | 45832 | Jun-26 | ATHENA | 22-Jul-25 | 20-May-26 | Unexpected increased demand | QUETIAPINE | As per Athena (HPRA shows 31.07.26 return date) | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 200MG PRO REL TABS PCO | 60TABS | 66923 | Intermittent supply - Limited supply | PCO | 12-Nov-25 | 22-May-26 | No reason provided | QUETIAPINE | As per PCO | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 400MG PRO REL TABS ORIGINAL | 60TABS | 31142 | No resupply date | ORIGINALIS | 18-Nov-25 | 20-May-26 | Low sales price in Ireland and demand | QUETIAPINE | As per Originalis | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 50MG PRO REL TABS | 60TABS | 45812 | 26th May 2026 | ATHENA | 05-Sep-25 | 25-May-26 | Unexpected increased demand | QUETIAPINE | As per Athena | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 50MG PRO REL TABS IMED | 60TABS | Limited stock due w/c 25th May 2026 | IMED | 11-Nov-25 | 22-May-26 | Export ban from licensed source country | QUETIAPINE | As per IMED | |||
| SEROQUEL XR 50MG PRO REL TABS PCO | 60TABS | 29216 | Intermittent supply - Limited supply | PCO | 12-Nov-25 | 22-May-26 | No reason provided | QUETIAPINE | As per PCO | EMP reimbursed for duration of HPRA registered shortage | |
| SERTRALINE KRKA 100MG FC TABS | 28TABS | 50561 | 2026 | KRKA PHARM | 19-Nov-25 | 20-May-26 | No reason provided | SERTRALINE | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SERTRALINE KRKA 50MG FC TABS | 28TABS | 50560 | 2026 | KRKA PHARM | 19-Nov-25 | 20-May-26 | No reason provided | SERTRALINE | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SIMVASTATIN TEVA 20MG FC TABS | 28TABS | 38247 | TBC | TEVA | 08-Apr-26 | 20-May-26 | Manufacturing delay | SIMVASTATIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SINGULAIR 10MG FC TABS | 28TABS | 46334 | 15th June 2026 | ORGANON | 21-Apr-26 | 20-May-26 | Unexpected increased demand | MONTELUKAST | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SITAGLIPTIN VIATRIS 100MG FC TABS | 28TABS | 66985 | w/c 20th July 2026 | VIATRIS | 10-Apr-26 | 20-May-26 | Manufacturing delay | SITAGLIPTIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SITAGLIPTIN/METFORMIN 50/1000MG FC TABS | 56TABS | 67044 | Early June 2026 | CLONMEL | 22-May-26 | No reason provided | SITAGLIPTIN/METFORMIN | As per Clonmel | |||
| SIX PLUS PARAPAED PARACET SUSP 250MG/5ML | 70ML | Discontinued | PINEWOOD | 14-Mar-22 | 19-May-26 | 19-May-26 | Quality issue | PARACETAMOL | As per Pinewood | ||
| SODIUM CHLORIDE 0.9% INJ BP 20ML | 1AMP | 8th June 2026 | B BRAUN | 12-May-26 | Manufacturing delay | SODIUM CHLORIDE | As per HPRA | ||||
| SOLIFENACIN SUCCINATE 5MG FC TABS | 30TABS | 29217 | 1st June 2026 | ACCORD HC | 16-Apr-26 | 20-May-26 | Shipping delay / distribution issue | SOLIFENACIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SOLPADOL CAPLETS 500MG/30MG TABS | 100TABS | 47082 | BSR stock available. | PHOENIX | 24-Feb-26 | 20-May-26 | Shipping delay / distribution issue | PARACETAMOL/CODEINE PHOS | As per Phoenix. Awaiting info n return date for Irish licensed pack | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SORAFENIB ACCORD 200MG FC TABS | 112TABS | 89279 | Back In Stock | ACCORD HC | 17-Feb-25 | 22-May-26 | 22-May-26 | API Shortage | SORAFENIB | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| SORMON 60MG PRO REL TABS ISOSORBIDE | 28TABS | 72058 | Jun-26 | VIATRIS | 15-Sep-25 | 20-May-26 | Manufacturing delay | ISOSORBIDE MONONITRATE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SPERIZAK 25MG PDR + SOLV PROREL SUSP/INJ | 1VIAL | 37426 | No return date | ACCORD HC | 23-Jul-25 | 20-May-26 | Shipping delay / distribution issue | RISPERIDONE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SPERIZAK 37.5MG PDR + SOLV PROREL INJ | 1VIAL | 37428 | No return date | ACCORD HC | 23-Jul-25 | 20-May-26 | Shipping delay / distribution issue | RISPERIDONE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SPERIZAK 50MG PDR + SOLV PROREL INJ | 1VIAL | 37429 | TBC Issue at Site | ACCORD HC | 23-Jul-25 | 20-May-26 | Shipping delay / distribution issue | RISPERIDONE | As per Accord. (HPRA shows Pendig return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SPIRONOLACTONE 100MG FC TABS | 100TABS | 72816 | 1st July 2026 | ACCORD HC | 23-Feb-26 | 20-May-26 | No reason provided | SPIRONOLACTONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SUMATRAN 100MG TABS SUMATRIPTAN | 6TABS | 68374 | Jun-26 | ROWA | 20-Mar-26 | 20-May-26 | Increase in sales | SUMATRIPTAN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SUMATRAN 50MG TABS SUMATRIPTAN | 6TABS | 68359 | May-26 | ROWA | 08-Apr-26 | 20-May-26 | Arriving into UD 18th May | SUMATRIPTAN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SUMATRIPTAN 100MG FC TABS | 6TABS | 36909 | No return date | ACCORD HC | 05-Feb-26 | 20-May-26 | Manufacturing delay | SUMATRIPTAN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SUMATRIPTAN 50MG FC TABS | 6TABS | 36908 | No return date | ACCORD HC | 05-Feb-26 | 20-May-26 | Manufacturing delay | SUMATRIPTAN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TEGRETOL 100MG/5ML ORAL SUSP | 300ML | 67482 | Early May 2026 | NOVARTIS | 09-Apr-26 | 20-May-26 | No reason provided | CARBAMAZEPINE | As per Novartis | EMP reimbursed for duration of HPRA registered shortage | |
| TELMISARTAN CLONMEL 40MG FC TABS | 28TABS | 64423 | TBC | CLONMEL | 13-Apr-26 | 20-May-26 | No reason provided | TELMISARTAN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TELMISARTAN CLONMEL 80MG FC TABS | 28TABS | 64424 | TBC | CLONMEL | 13-Apr-26 | 20-May-26 | No reason provided | TELMISARTAN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TELMISARTAN HCTZ CLONMEL 80MG/12.5MG TAB | 28TABS | 13310 | Mid June 2026 | CLONMEL | 24-Feb-26 | 20-May-26 | No reason provided | TELMISARTAN/HCTZ | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TELMISARTAN HCTZ ROWA 80MG/12.5MG TABS | 28TABS | 13164 | July / August 2026 | ROWA | 04-May-26 | 22-May-26 | Unexpected increased demand | TELMISARTAN/HCTZ | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TENDROTIL SR 2MG PRO REL HARD CAPS | 28CAPS | 31598 | No return date | ACCORD HC | 04-Feb-25 | 20-May-26 | Quality issue | TOLTERODINE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TENDROTIL SR 4MG PRO REL HARD CAPS | 28CAPS | 31643 | No return date | ACCORD HC | 17-Dec-24 | 20-May-26 | Quality issue | TOLTERODINE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TENOFOVIR DISOPROXIL MYLAN 245MG FC TABS | 30TABS | 88860 | No back in stock date available at the moment | VIATRIS | 20-May-25 | 20-May-26 | Manufacturing delay | TENOFOVIR DISOPROXIL | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TETRIDAR 20MCG/80MCL SOLN FOR INJ PFP | 1PENS | 89028 | Sep-26 | TEVA | 08-Apr-26 | 20-May-26 | Manufacturing delay | TERIPARATIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TEVAQUEL 100MG FC TABS QUETIAPINE | 60TABS | 46053 | 10th July 2026 | TEVA | 09-Apr-26 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TEVAQUEL 200MG FC TABS QUETIAPINE | 60TABS | 46054 | Aug-26 | TEVA | 10-Apr-26 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TEVAQUEL 25MG FC TABS QUETIAPINE | 60TABS | 46052 | 29th June 2026 | TEVA | 13-May-26 | 22-May-26 | Manufacturing delay | QUETIAPINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| TEVAQUEL 300MG FC TABS QUETIAPINE | 60TABS | 46055 | OOS expected 31st May - 22nd June 2026 | TEVA | 15-May-26 | Manufacturing delay | QUETIAPINE | As per HPRA | |||
| TEVAQUEL XL 300MG PRO REL TAB QUETIAPINE | 60TABS | 67832 | Aug-26 | TEVA | 23-Jun-25 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TEVAQUEL XL 400MG PRO REL TAB QUETIAPINE | 60TABS | 67965 | Jun-26 | TEVA | 05-Aug-25 | 21-May-26 | No reason provided | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TEVAQUEL XL 50MG PRO REL TABS QUETIAPINE | 60TABS | 65982 | Aug-26 | TEVA | 24-Nov-25 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TICAGRELOR ROWEX 90MG FC TABS | 56TABS | 67336 | TBC | ROWEX | 10-Dec-25 | 20-May-26 | Issues with site | TICAGRELOR | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TIPOL 125MG SUPPOSITORIES PARACETAMOL | 10SUPPOS | 68183 | Early July 2026 | CLONMEL | 11-Mar-26 | 20-May-26 | Manufacturing delay | PARACETAMOL | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TIPOL 500MG SUPPOSITORIES PARACETAMOL | 10SUPPOS | 68472 | Early July 2026 | CLONMEL | 22-May-26 | No reason provided | PARACETAMOL | As per Clonmel | |||
| TIPURIC 300MG TABS ALLOPURINOL | 100TABS | 11398 | Early September 2026 | CLONMEL | 13-Apr-26 | 22-May-26 | No reason provided | ALLOPURINOL | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TOLTERODINE TARTRATE 2MG FC TABS | 56TABS | 36894 | TBC | ACCORD HC | 20-Mar-25 | 20-May-26 | Manufacturing delay | TOLTERODINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TOVIAZ 8MG PRO REL TABS | 28TABS | 47575 | OOS 1st - 15th June 2026 | PFIZER | 18-May-26 | Unexpected increased demand | FESOTERODINE | As per HPRA | |||
| TRACRIUM 10MG/ML SOLN/INJ/INF 2.5ML AMPS | 5AMP | Awaiting update | SANDOZ | 16-Jan-26 | 01-Apr-26 | Manufacturing delay | ATRACURIUM | As per Rowa | |||
| TRANSIDERM-NITRO 10MG/24HRS PATCH | 28PATCH | 51544 | 26th May 2026 | SANDOZ | 08-May-26 | 25-May-26 | Short term outage | GLYCERYL TRINITRATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TRANSIDERM-NITRO 15MG/24HRS PATCH | 30PATCH | 50040 | 26th May 2026 | SANDOZ | 08-May-26 | 25-May-26 | Short term outage | GLYCERYL TRINITRATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TRANSIDERM-NITRO 5MG/24HRS PATCH | 28PATCH | 51261 | 26th May 2026 | SANDOZ | 08-May-26 | 25-May-26 | Short term outage | GLYCERYL TRINITRATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TRUSITEV SR 2MG PRO REL HARD CAPS | 28CAPS | 42046 | Jul-26 | TEVA | 09-Jan-25 | 20-May-26 | No reason provided | TOLTERODINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TRUSITEV SR 4MG PRO REL HARD CAPS | 28CAPS | 42052 | Jul-26 | TEVA | 13-Feb-25 | 20-May-26 | No reason provided | TOLTERODINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TYLEX 30MG/500MG HARD CAPS | 100CAPS | 50555 | Back In Stock | UCB PHARMA | 06-Apr-26 | 25-May-26 | 25-May-26 | Unexpected increased demand | CODEINE PHOS/PARACETAMOL | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| UROGRAFIN 30% SOLN FOR INF | 250ML | 31st May 2027 | BAYER | 10-Mar-26 | 30-Mar-26 | Quality issue | SOD AMIDOTRI/MEGLUM AMIDO | As per HPRA | |||
| VALACICLOVIR TEVA 500MG FC TABS | 30TABS | 60563 | Jul-26 | TEVA | 14-May-26 | 22-May-26 | Manufacturing delay | VALACICLOVIR | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VALSARTAN HCTZ TEVA 80MG/12.5MG FC TABS | 28TABS | 73757 | Jun-26 | TEVA | 23-Apr-26 | 20-May-26 | No reason provided | VALSARTAN/HCTZ | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VALSARTAN TEVA 160MG FC TABS | 28TABS | 73735 | 20th July 2026 | TEVA | 24-Apr-26 | 20-May-26 | Shipping delay / distribution issue | VALSARTAN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VARENICLINE TEVA 0.5MG + 1MG FC TABS | 1PACK | 67441 | May-26 | TEVA | 14-May-26 | 22-May-26 | No reason provided | VARENICLINE | As per TEVA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VENLOFEX 150MG PRO REL CAPS VENLAFAXINE | 28CAPS | 79172 | 31st August 2026 | VIATRIS | 04-Apr-25 | 20-May-26 | Manufacturing delay | VENLAFAXINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VIDENE 10% ALCOHOLIC TINCTURE | 500ML | Pending | ECOLAB | 19-Nov-25 | 05-Jan-26 | Manufacturing delay | POVIDONE-IODINE | As per HPRA | |||
| VIRALIEF 50MG/G CREAM ACICLOVIR | 2G | Early February 2027 | CLONMEL | 21-May-26 | 22-May-26 | Quality issue | ACICLOVIR | As per Clonmel | |||
| VISUDYNE 15MG PDR FOR SOLN/INF | 1VIAL | Continued shortages, until the end of 2026 (Exempt Medicinal Product avail) | ATHENA | 29-Mar-23 | 17-Dec-25 | Manufacturing delay | VERTEPORFIN | As per Athena | |||
| VITAFEN 100MG FC TABS | 60TABS | 35974 | July 2026 (tentative) | PHOENIX | 15-Apr-25 | 25-May-26 | No reason provided | ACECLOFENAC | As per Phoenix Labs. Exempt Medicinal Product avail. Temp code applies | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| WARFARIN TEVA 1MG TABS | 100TABS | 61701 | 30th June 2026 | TEVA | 27-Apr-26 | 20-May-26 | Manufacturing delay | WARFARIN | As per HPRA | temporary GMS Code of 55532 | |
| WARFARIN TEVA 3MG TABS | 100TABS | 61717 | Jun-26 | TEVA | 01-Dec-25 | 20-May-26 | Manufacturing delay | WARFARIN | As per Teva (HPRA shows 23.03.26 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZADITEN 0.25MG/ML EYE DROPS SOLN | 5ML | 63281 | Jul-26 | LAB THEA | 11-Jul-25 | 20-May-26 | Quality issue | KETOTIFEN | As per Lab Thea (HPRA shows 30.09.26 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZANAFLEX 4MG TABS | 120TABS | 54424 | Jun-26 | TEVA | 12-Feb-26 | 20-May-26 | No reason provided | TIZANIDINE | As per Teva. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZINDACLIN 1% GEL | 30G | 59816 | 30th September 2026 | ASPIRE PH | 06-Mar-23 | 25-May-26 | Distribution issue | CLINDAMYCIN | As per HPRA. EMP avail. HPRA shows PA23142/016/001 as Not Marketed May 2026 | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZINERYT 40MG+12 MG PDR/SOLVENT/CUT SOLN | 30ML | 91995 | TBC | ATHENA | 11-Mar-26 | 20-May-26 | Manufacturing delay | ERYTHROMYCIN/ZINC ACETATE | As per Athena | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZINNAT 250MG FC TABS | 14TABS | 59870 | Jun-26 | SANDOZ | 09-Jan-26 | 20-May-26 | Production delays | CEFUROXIME | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZOFRAN 4MG FC TABS | 30TABS | 53163 | OOS expected end June - end July/ early August 2026 | ROWEX | 08-May-26 | 22-May-26 | Increase in sales | ONDANSETRON | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZOFRAN 4MG/2ML SOLN/INJ/INF | 10AMP | Awaiting update | ROWEX | 01-Oct-25 | 13-Mar-26 | Checking with site to see what delay is with receiving stock | ONDANSETRON | As per Rowa | |||
| ZOLEDRONIC ACID TEVA 4MG/5ML CONC/INF | 1VIAL | 18th June 2026 | TEVA | 09-Apr-26 | Unexpected increased demand | ZOLEDRONIC ACID | As per HPRA | ||||
| ZUBSOLV 1.4MG/0.36MG SUBLINGUAL TABS | 28TABS | 46001 | Early June 2026 | ACCORD HC | 13-Apr-26 | 22-May-26 | Shipping delay / distribution issue | BUPRENORPHINE/NALOXONE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZUBSOLV 2.9MG/0.71MG SUBLINGUAL TABS | 28TABS | 46002 | Early June 2026 | ACCORD HC | 19-Aug-25 | 22-May-26 | Manufacturing delay | BUPRENORPHINE/NALOXONE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZUBSOLV 8.6MG/2.1MG SUBLINGUAL TABS | 28TABS | 46005 | Early June 2026 | ACCORD HC | 13-Apr-26 | 22-May-26 | Shipping delay / distribution issue | BUPRENORPHINE/NALOXONE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list |
💊
Ask a question
about medicine shortages
about medicine shortages
/* Mobile only */
@media (min-width: 769px) {
#medicineBubble,
#medicineChatWrapper {
display: none !important;
}
}
/* Centered bubble */
#medicineBubble {
position: fixed;
inset: 0;
margin: auto;
width: 100px;
height: 100px;
background: #8CC63F;
border-radius: 50%;
box-shadow: 0 10px 25px rgba(0,0,0,.3);
z-index: 999999;
display: flex;
align-items: center;
justify-content: center;
text-align: center;
color: #fff;
font-size: 11px;
font-weight: 600;
cursor: pointer;
}
#medicineBubble .icon {
font-size: 24px;
display: block;
margin-bottom: 4px;
}
/* Chat wrapper (hidden initially) */
#medicineChatWrapper {
display: none; /* MUST be hidden initially */
position: fixed;
inset: 0;
width: 100vw;
height: 100dvh;
flex-direction: column;
z-index: 1000000;
background: #fff;
overflow: hidden;
display: none;
}
#medicineChatHeader {
padding: calc(8px + env(safe-area-inset-top, 0px)) 12px 8px 12px;
display: flex;
justify-content: flex-end;
background: rgba(0,0,0,.05);
flex-shrink: 0;
}
#closeMedicineChat {
background: rgba(0,0,0,.85);
color: #fff;
border: none;
padding: 8px 12px;
border-radius: 999px;
font-size: 14px;
}
#medicineChatIframe {
flex: 1;
width: 100%;
border: none;
}
// Force chat hidden on page load
document.getElementById('medicineChatWrapper').style.display = 'none';
function openMedicineChat() {
document.getElementById('medicineChatWrapper').style.display = 'flex';
document.getElementById('medicineBubble').style.display = 'none';
document.body.style.overflow = 'hidden';
}
function closeMedicineChat() {
document.getElementById('medicineChatWrapper').style.display = 'none';
document.getElementById('medicineBubble').style.display = 'flex';
document.body.style.overflow = '';
}
💊
Ask a question
about medicine shortages
about medicine shortages
- Medicines Shortages List June 2026
- Medicines Shortages List May 2026
- Medicines Shortages List Apr 2026
- Medicines Shortages List Mar 2026
- Medicines Shortages List Feb 2026
- Medicines Shortages List Jan 2026
- Medicines Shortages List Dec 2025
- Medicines Shortages List Nov 2025
- Medicines Shortages List Oct 2025
- Medicines Shortages List Sep 2025
- Medicines Shortages List Aug 2025
- Medicines Shortages List July 2025
- List Item
- List Item